ArticleInvestigational new drugs2019

Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.

Jian-Chun Duan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.